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Resumo
Introdução: A esclerose múltipla (EM) é a doença inflamatória desmielinizante imunomediada 
que mais frequentemente afecta o sistema nervoso central. Aproximadamente 20% dos doentes 
têm nevrite óptica como manifestação inicial da doença. A sua frequência, heterogeneidade e 
ausência de tratamento curativo tornam esta patologia um desafio diagnóstico e terapêutico tanto 
para o doente como para o médico.
material e métodos: Estudo retrospectivo de 133 olhos de 87 indivíduos, 38 doentes com es-
clerose múltipla (Grupo 1), 9 doentes com nevrite óptica isolada (Grupo 2) e 40 indivíduos 
saudáveis (Grupo 3) da Consulta de Neuroftalmologia do Centro Hospitalar de Lisboa Central, 
através da consulta do processo e exames complementares de diagnóstico, entre Janeiro de 2013 
e Agosto de 2015.
Foram caracterizados os doentes de acordo com o género, idade, anos de seguimento, melhor 
acuidade visual corrigida, presença de outras anomalias oculares concomitantes e episódios de 
nevrite óptica. Foram excluídos doentes com outras patologias oculares.
Foi realizada uma tomografia de coerência óptica (OCT Spectralis, Heidelberg Engineering) da 
região macular, seguida de segmentação automática das camadas retinianas. 
O estudo estatístico permitiu calcular diferenças estatisticamente significativas entre os diferen-
tes grupos do estudo. 
Resultados: Nos 87 doentes avaliados, a média de idades do grupo 1 foi de 41.55 anos, versus 
36.88 do grupo 2 e 44.73 do grupo de controlo. A mediana da idade do diagnóstico nos doentes 
com esclerose múltipla foi de 33.73 anos e do tempo de seguimento de 8.01 anos, e no grupo da 
nevrite óptica isolada de 34.33, com 2.88 anos de seguimento. A melhor acuidade visual corrigi-
da variou entre 0.2 e 1.0 no grupo 1 e 0.5 a 1.0 no grupo 2.
Nos doentes com antecedentes de nevrite óptica isolada ou associada a esclerose múltipla obser-
vou-se uma diminuição significativa (p<0.05) da espessura média da retina com diminuição da 
camada de fibras nervosas, da camada de células ganglionares e da plexiforme interna em relação 
ao grupo controlo.
Conclusões: As espessuras, especialmente das camadas mais internas da retina (camada de fi-
bras nervosas, camada de células ganglionares e plexiforme interna), estavam reduzidas de for-
ma estatisticamente significativa (p<0.05) em relação ao grupo controlo. 
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Introduction: Multiple sclerosis (MS) is an inflammatory immune-mediated demyelinating 
disease that frequently affects the central nervous system. Approximately 20% of patients have 
optic neuritis as the first manifestation of the disease. Its frequency, heterogeneity and absence 
of definitive treatment make it a therapeutic and diagnostic challenge for both the patient and 
the clinician.
material and methods: Retrospective study of 133 eyes of 87 patients, 38 patients with MS 
(Group 1), 9 patients with isolated optic neuritis (Group 2) and 40 healthy patients (Group 3) 
from the Neurophthalmology Department of Centro Hospitalar de Lisboa Central from January 
2013 to August 2015.
Patients were characterized according to gender, age, years of follow-up, best corrected 
visual acuity, presence of other ocular disorders and episodes of optic neuritis. Patients with 
other ocular pathologies were excluded. 
Optical coherence tomography (OCT Spectralis, Heidelberg Engineering) of the macular 
region was done in all patients, followed by automatic segmentation of the retinal layer. Statisti-
cal tests were made to calculate statistically significant results between different groups.
Results: Of the 87 patients evaluated, the mean age in Group 1 was 41.55 compared to 36.88 
in Group 2 and 44.73 in the control group. Mean age of diagnosis for patients with MS was 33.73 
years with a mean follow up of 8.01 years, whereas patients with isolated optic neuritis had a 
mean age of diagnosis of 34.33 years, with a mean follow-up of 2.88 years. Best corrected visual 
acuity ranged from 0.2 to 1.0 in Group 1 and 0.5 to 1.0 in Group 2. 
In patients with previous episodes of optic neuritis isolated or associated with multiple scle-
rosis we observed a statistically significant (p<0.05) reduction of the average retinal thickness 
as well as a thinner retinal nerve fiber layer, ganglion cell layer and inner plexiform layer when 
compared to the control group.
Conclusion: Thickness of the internal retinal layers was reduced (retinal nerve, ganglion cell 
and inner plexiform layer) in a statistically significant (p<0.05) when compared to the control 
group.
Keywords 
Multiple sclerosis; optical coherence tomography; optic neuritis; ganglion cell layer.
IntRoduCtIon
Multiple sclerosis (MS) is a chronic, predominantly 
immune-mediated, inflammatory and demyelinating disease 
of the central nervous system (CNS) characterized by suba-
cute neurologic deficits correlating with CNS lesions, sepa-
rated in time and space, excluding other possible diseases. 
Approximately 20% of MS patients present with acute optic 
neuritis (AON) as a first demyelinating event and about 40 
to 70% experience ON at some point during the course of 
the disease1.
Optical coherence tomography (OCT) is a noninvasive, 
noncontact, reproducible, quantitative technique that uses 
the interference patterns produced by low coherence light 
to generate high-resolution (<5μm) from optical scatte-
ring media (e.g. retina). This technique has been used to 
define and differentiate specific forms of optic neuropathy, 
document changes in retinal nerve fiber layer thickness 
(RNFL) and macular volume2 over time and help corre-
late structural retinal nerve fiber layer changes with visual 
function.
Since the RNFL is composed only of unmyelinated 
axons of the retinal ganglion cells (which convey informa-
tion from the retina to the lateral geniculate nucleus), mea-
suring RNFL thickness can be a viable method for monito-
ring axonal loss in MS patients. Following the publication 
of the first quantitative OCT study of RNFL thickness in 
multiple sclerosis (MS) in 1999,1,3 there has been a rapidly 
growing interest in various applications of OCT in the diag-
nosis and management of patients with MS, both in those 
with optic neuritis (MS ON+) and those without optic neu-
ritis (MS ON-). 
Subsequently, OCT studies turned to the segmentation 
of retinal layers from which the individual retinal layers 
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can be delimited, qualitatively and quantitatively assessed 
to extend the analysis of axonal damage (RNFL) to neu-
ronal degeneration. Ganglion cell layer thinning has been 
proved to be a sensitive marker to detect damage even in the 
absence of a previous episode of ON. 
This study aims to determine changes in thickness of 
the eight different retinal layers in patients with MS ON+, 
MS ON- and clinically isolated syndrome (demyelinating 
lesion suggestive of MS that does not fulfill the criteria for 
MS diagnosis) and compare them with healthy subjects 
by using an automated segmentation program of spectral 
domain optical coherence tomography.
Since the heterogeneity of the MS disease course 
remains a challenge for patient management and treatment, 
our study tries to evaluate if inner retinal thickness can 
serve as a direct biomarker for monitoring the course of this 
disease.
mateRIal and methods
Retrospective study of 133 eyes of 87 individuals, 47 
patients and 40 healthy controls from the Multiple Sclero-
sis and Neuro-Ophthalmology Department of Hospital de 
Santo António dos Capuchos, between January 2013 and 
August 2015. 
The design of this study followed the Declaration of 
Helsinki principles. All participants provided written infor-
med consent. 
Patients were characterized according to gender, age, 
years of follow-up, episodes of optic neuritis and treatment. 
All participants underwent a full ophthalmologic examina-
tion including best corrected visual acuity, biomicroscopy, 
Goldmann applanation tonometry, and ophthalmoscopy. 
Participants were excluded if there was any history of a 
comorbidity that could plausibly account for the presence 
of macular or neuropathy, including a prior history of glau-
coma, uveitis, diabetes, retinal vein occlusion, age-related 
macular degeneration, retinosquisis, or refractive errors of 
more or less than six diopters. This happened in two patients 
with subclinical epiretinal membrane and macular edema.
Study participants were recruited and divided in three 
groups: Group 1 included 38 patients with MS, subdivided 
in eyes with optic neuritis (ON+) (n=44), or without optic 
neuritis (ON-) (n= 31); Group 2 with 9 patients with cli-
nically isolated syndrome (CIS) subdivided in eyes with 
optic neuritis (ON+) (n=10) or without optic neuritis (ON-) 
(n=8); Group 3 of healthy controls (n=40). 
Patients with MS were diagnosed according to the 
2010 modified McDonald criteria by treating neurologists. 
In patients with CIS, other diseases such as neuromyelitis 
optica (NMO), and chronic relapsing inflammatory neuro-
pathy were excluded (negative NMO-IgG). All were treated 
with corticosteroids and one had another episode of optic 
neuritis in the other eye during follow-up. Disease duration 
was defined as the time from the first clinical symptom attri-
butable to multiple sclerosis to the date of OCT evaluation. 
Patients with acute optic neuritis or optic disc edema within 
three months of the examination were excluded from the 
study. 
All patients underwent retinal OCT imaging and auto-
mated retinal segmentation to identify each retinal layer and 
to quantify its thickness. OCT was performed by an expe-
rienced operator using spectral-domain OCT (Heidelberg 
Spectralis, Heidelberg Engineering, Germany). 
Macular scanning was obtained and qualitatively asses-
sed for the presence of other macular pathologies. Macular 
segmentation was performed using Heidelberg Eye Explo-
rer software provided by the manufacturer. Corresponding 
data was obtained from single horizontal axial scans to 
separate the retina into 8 layers: 1- nerve fiber layer; 2- gan-
glion cell layer; 3-inner plexiform layer; 4- inner nuclear 
layer; 5- outer plexiform layer; 6- outer nuclear layer; 7- 
photoreceptor layer; 8- retinal pigment epithelium.
Scans were centered at the fovea and obtained at a radius 
of 3 to 6 mm from the central, superior, inferior, nasal and 
temporal sectors. Values of mean thickness, nasal (N), 
superonasal (SN), inferonasal (IN), temporal (T), temporo-
-nasal (TN) and superonasal (SN) thickness were collected 
from all retinal layers. All scans were assessed before seg-
mentation analysis and low quality scans were rejected.
Statistical analysis was performed using SPSS software. 
Mean layer and sectorial thickness were compared between 
the different groups using Student t test, considering P 
values less than 0.05 statistically significant.
Results 
In this retrospective study of 133 eyes of 87 indivi-
duals, 47 patients and 40 healthy controls, participants were 
recruited and divided in three groups (Table I): 
- Group 1 included 75 eyes of 38 patients with MS, 
subdivided in eyes with previous acute optic neuri-
tis (ON+, N=44) or without previous optic neuritis 
(ON-, N= 31). In this group mean age was 41.55 ± 
12.38 years, with a mean follow-up of 8.02 ± 8.24 
years.
- Group 2 included 18 eyes of 10 patients with cli-
nically isolated syndrome (CIS) subdivided in eyes 
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with optic neuritis (ON+, N=10) or without optic 
neuritis (ON-, N=8). These patients had a mean age 
of 34.89 ± 11.75 years and a mean follow-up of 2.88 
± 3.09 years.
- Group 3 (control) included 40 eyes of 40 healthy 
controls with a mean age of 45.62 ± 13.70 years.
Patient age ranged from 21 years to 68 years (Group 1 
and 2) and the ratio of women to men was approximately 
2.13:1 (32 women, 15 men). 
No significant difference in age was found between 
groups (two-sample student’s t test, p>0.05) but Group 1 
and 2 were found to differ significantly regarding disease 
duration (two-sample student’s t test, p<0.001). 
All 87 patients underwent retinal OCT imaging and 
automated retinal segmentation to identify each retinal 
layer and to quantify its thickness.
average total retinal thickness
In this study the average total retinal thickness was 
initially compared between MS ON + eyes and MS ON- 
of Group 1 and 2 with the eyes of control Group 3. This 
revealed a statistical significant difference (Student T test, 
p< 0.05) between MS ON+ and the control group, demons-
trating a reduced macular thickness in MS ON + eyes at 
the fovea and also all sectors (Table II). Although MS ON- 
eyes didn’t reveal a statistically significant reduction at the 
fovea, they did in all other sectors except in T6 (Table III). 
Both CIS ON+ and CIS ON- eyes did not reveal a sta-
tistical significant difference (Student T test, p<0.05) to the 
control group.
There was no statistical difference in macular volume 
between MS ON+ and ON- eyes.
Retinal layer thickness
After comparing total macular thickness, the thickness 
of all eight retinal layers was measured (RNFL, GCL, IPL, 
INL, OPL, ONL, RPE, FR) with scans centered at the fovea 
and at a radius of 3 to 6 mm from the central, superior, infe-
rior, nasal and temporal sectors. Values of mean thickness, 
nasal (N), superonasal (SN), inferonasal (IN), temporal (T), 
temporo-nasal (TN) and superonasal (SN) thickness were 
collected from all retinal layers (Table IV).
Retinal nerve Fiber layer
Statistical significant differences (p<0.05) were found 
between MS ON+ eyes and Control Group 3, with a reduc-
tion in average retinal thickness at the RNFL, with a more 
significant reduction in respectively the superior and infe-
rior sectors. Although a statistical significance was not 
obtained in the temporal and nasal sectors, it showed a 
statistical trend towards reduction. This reduction did not 
respect the ISNT rule for glaucomatous eyes. MS ON- only 
showed a significant reduction in the temporal sector of 
both inner and outer ring and in the nasal sector of the outer 
ring. Superior RNFL thickness was reduced in MS ON+ 
compared to MS ON- (p<0.05). CIS ON- had a significantly 
reduced RNFL thickness (p<0.05) in the superior sector of 
the inner and outer ring whereas CIS ON+ had a temporal 
and nasal reduction also of both rings.
Ganglion Cell layer
GCL was found to be significantly thinner (p<0.05) in 
both MS ON+ and MS ON- eyes compared with Control 
Group 3, with a reduction in average retinal thickness in all 
sectors except for the central one. Central GCL thickness 
was reduced in MS ON+ compared to MS ON- (p<0.05). 
CIS ON+ had a significant reduced GCL thickness (p<0.05) 
in the superior sector of the outer ring whereas CIS ON- did 
not show a significant reduction.
Inner Plexiform layer
The calculated measurements revealed a thinner IPL in 
all sectors (p<0.001) in MS ON+ and in all sectors except 
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table I | Baseline demographic and clinical characteristics.
Group 1 (MS patients) Group 2 (MS patients)
Patients (eyes) 38 (75) 9 (18)
age, years, mean (sd) 41.55 (±12.38) 34.89 (±11.75)
Female (%) 25 (65.79%) 7 (77.78%)
BCVa (snellen) 0.862 (±0.21) 0.986 (±0.05)
disease duration, years 8.01 (±8.24) 2.88 (±3.09)
eyes with a previous history of aon 44 (58.7%) 10 (55%)
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table II | Baseline demographic and clinical characteristics.
Inner ring outer Ring ms on+ (n=31) Control Group (n=40) p Value
Central total retinal thickness,
μm, mean
268.00 277.68 0.04
Superior
Temporal
Inferior
Nasal
Superior
Temporal
Inferior
Nasal
324.05
312.52
318.45
331.65
287.90
280.87
282.39
298.19
346.80
331.18
340.50
347.40
301.55
285.85
291.40
316.68
0.001
0.001
0.001
0.001
0.001
0.001
0.001
0.001
Central RNFL thickness, μm, mean 12,43 12.65 0.713
Superior
Temporal
Inferior
Nasal
Superior
Temporal
Inferior
Nasal
22,68
18,16
22,36
20,34
30,86
20,45
32,73
37,91
24.68
17.33
25.00
20.88
37.40
18.80
38.98
48.33
0.033
0.118
0.005
0.458
0.001
0.169
0.001
0.001
Central GCL thickness, μm, mean 12,98 15.70 0.008
Superior
Temporal
Inferior
Nasal
Superior
Temporal
Inferior
Nasal
41,52
36,07
40,09
39,09
29,89
29,50
29,50
31,50
51.58
46.80
51.35
51.38
35.55
35.90
34.63
39.00
0.001
0.001
0.001
0.001
0.001
0.001
0.001
0.001
Central IPL thickness, μm, mean 19,20 21.77 0.001
Superior
Temporal
Inferior
Nasal
Superior
Temporal
Inferior
Nasal
33,77
33,80
33,39
34,43
24,36
27,82
24,16
24,36
41.77
41.56
40.26
42.67
28.59
32.36
27.97
29.51
0.001
0.001
0.001
0.001
0.001
0.001
0.001
0.001
Central INL thickness, μm, mean 18,50 20.15 0.199
Superior
Temporal
Inferior
Nasal
Superior
Temporal
Inferior
Nasal
41,23
37,52
40,36
40,43
31,07
33,43
31,84
34,39
41.00
36.87
39.74
39.79
32.51
33.67
31.72
34.64
0.773
0.364
0.443
0.435
0.011
0.714
0.864
0.656
Central OPL thickness, μm, mean 24,91 25.87 0.484
Superior
Temporal
Inferior
Nasal
Superior
Temporal
Inferior
Nasal
33,32
30,77
34,11
34,30
26,57
27,25
27,18
28,70
34.62
30.97
33.33
34.05
27.05
26.79
26.74
28.72
0.443
0.865
0.647
0.898
0.433
0.401
0.521
0.987
Central ONL thickness, μm, mean 90,30 93.79 0.183
Superior
Temporal
Inferior
Nasal
Superior
Temporal
Inferior
Nasal
69,70
73,52
68,32
73,02
59,30
56,68
51,89
55,36
69.21
74.41
68.08
74.46
61.00
58.62
53.46
57.62
0.835
0.695
0.928
0.614
0.319
0.222
0.377
0.224
Central RPE thickness, μm, mean 18,20 17.10 0.139
Superior
Temporal
Inferior
Nasal
Superior
Temporal
Inferior
Nasal
15,64
14,95
14,86
15,80
13,93
13,05
13,11
13,59
15.28
14.33
14.64
15.49
13.21
12.74
13.00
13.31
0.439
0.173
0.585
0.506
0.099
0.269
0.673
0.425
Central FR thickness, μm, mean 90,75 89.33 0.255
Superior
Temporal
Inferior
Nasal
Superior
Temporal
Inferior
Nasal
81,39
81,77
80,57
83,14
79,23
77,98
76,80
78,82
81.36
81.54
80.18
82.51
78.85
78.05
77.51
78.77
0.970
0.757
0.539
0.425
0.455
0.886
0.146
0.930
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table III | mean thickness of all 10 retinal layers (central and sectorial) obtained by automatic segmentation of the spectralis 
oCt in ms on- eyes and control group.
Inner ring outer Ring ms on- (n=31) Control Group (n=40) p Value
Central total retinal thickness,
μm, mean
274.35 277.68 0.515
Superior
Temporal
Inferior
Nasal
Superior
Temporal
Inferior
Nasal
332.03
318.06
328.94
331.65
287.90
280.87
282.39
298.19
346.80
331.18
340.50
347.40
301.55
285.85
291.40
316.68
0.001
0.028
0.021
0.002
0.001
0.310
0.053
0.001
Central RNFL thickness, μm, mean 13.26 12.65 0.323
Superior
Temporal
Inferior
Nasal
Superior
Temporal
Inferior
Nasal
25.52
19.35
23.55
21.58
34.84
21.68
36.26
42.06
24.68
17.33
25.00
20.88
37.40
18.80
38.98
48.33
0.485
0.048
0.220
0.534
0.086
0.042
0.138
0.010
Central GCL thickness, μm, mean 14.84 15.70 0.439
Superior
Temporal
Inferior
Nasal
Superior
Temporal
Inferior
Nasal
44.61
40.03
42.87
41.55
31.16
31.74
31.68
34.00
51.58
46.80
51.35
51.38
35.55
35.90
34.63
39.00
0.005
0.004
0.001
0.001
0.001
0.003
0.006
0.001
Central IPL thickness, μm, mean 21.26 21.77 0.552
Superior
Temporal
Inferior
Nasal
Superior
Temporal
Inferior
Nasal
37.29
38.61
37.52
37.90
25.65
30.06
25.48
26.03
41.77
41.56
40.26
42.67
28.59
32.36
27.97
29.51
0.001
0.014
0.107
0.002
0.001
0.007
0.004
0.001
Central INL thickness, μm, mean 19.48 20.15 0.618
Superior
Temporal
Inferior
Nasal
Superior
Temporal
Inferior
Nasal
41.55
37.61
40.39
41.10
30.90
33.35
31.13
34.10
41.00
36.87
39.74
39.79
32.51
33.67
31.72
34.64
0.538
0.372
0.519
0.174
0.010
0.664
0.439
0.432
Central OPL thickness, μm, mean 26.19 25.87 0.818
Superior
Temporal
Inferior
Nasal
Superior
Temporal
Inferior
Nasal
32.42
32.39
33.71
32.58
26.32
27.29
26.71
28.32
34.62
30.97
33.33
34.05
27.05
26.79
26.74
28.72
0.249
0.341
0.851
0.442
0.270
0.487
0.967
0.659
Central ONL thickness, μm, mean 91.26 93.79 0.341
Superior
Temporal
Inferior
Nasal
Superior
Temporal
Inferior
Nasal
70.58
73.55
70.06
74.87
60.74
56.68
54.19
56.77
69.21
74.41
68.08
74.46
61.00
58.62
53.46
57.62
0.615
0.744
0.491
0.878
0.888
0.399
0.698
0.643
Central RPE, μm, mean 17.10 17.10 0.993
Superior
Temporal
Inferior
Nasal
Superior
Temporal
Inferior
Nasal
15.26
14.48
14.97
15.10
14.39
12.84
13.06
13.48
15.28
14.33
14.64
15.49
13.21
12.74
13.00
13.31
0.959
0.738
0.431
0.355
0.063
0.723
0.820
0.633
Central FR thickness, μm, mean 89.87 89.33 0.713
Superior
Temporal
Inferior
Nasal
Superior
Temporal
Inferior
Nasal
80.81
81.23
80.29
82.19
78.48
77.55
76.52
78.26
81.36
81.54
80.18
82.51
78.85
78.05
77.51
78.77
0.506
0.712
0.859
0.692
0.537
0.354
0.064
0.362
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table IV | mean thickness of all 10 retinal layers (central and sectorial) obtained by automatic segmentation of the spectralis 
oCt in ms on+ eyes and ms on-.
Inner ring outer Ring ms on+ (n=44) ms on- (n=31) p Value
Central total retinal thickness,
μm, mean
268,00 274,35 0,200
Superior
Temporal
Inferior
Nasal
Superior
Temporal
Inferior
Nasal
324,05
312,52
318,45
324,39
281,20
271,34
273,61
291,61
332,03
318,06
328,94
331,65
287,90
280,87
282,39
298,19
0,151
0,404
0,077
0,205
324,05
312,52
318,45
324,39
Central RNFL thickness, μm, mean 12,43 13,26 0,259
Superior
Temporal
Inferior
Nasal
Superior
Temporal
Inferior
Nasal
22,68
18,16
22,36
20,34
30,86
20,45
32,73
37,91
25,52
19,35
23,55
21,58
34,84
21,68
36,26
42,06
0,038
0,249
0,374
0,319
22,68
18,16
22,36
20,34
Central GCL thickness, μm, mean 12,98 14,84 0,034
Superior
Temporal
Inferior
Nasal
Superior
Temporal
Inferior
Nasal
41,52
36,07
40,09
39,09
29,89
29,50
29,50
31,50
44,61
40,03
42,87
41,55
31,16
31,74
31,68
34,00
0,198
0,159
0,307
0,393
41,52
36,07
40,09
39,09
Central IPL thickness, μm, mean 19,20 21,26 0,007
Superior
Temporal
Inferior
Nasal
Superior
Temporal
Inferior
Nasal
33,77
33,80
33,39
34,43
24,36
27,82
24,16
24,36
37,29
38,61
37,52
37,90
25,65
30,06
25,48
26,03
0,019
0,002
0,012
0,049
33,77
33,80
33,39
34,43
Central INL thickness, μm, mean 18,50 19,48 0,337
Superior
Temporal
Inferior
Nasal
Superior
Temporal
Inferior
Nasal
41,23
37,52
40,36
40,43
31,07
33,43
31,84
34,39
41,55
37,61
40,39
41,10
30,90
33,35
31,13
34,10
0,721
0,911
0,979
0,401
41,23
37,52
40,36
40,43
Central OPL thickness, μm, mean 24,91 26,19 0,369
Superior
Temporal
Inferior
Nasal
Superior
Temporal
Inferior
Nasal
33,32
30,77
34,11
34,30
26,57
27,25
27,18
28,70
32,42
32,39
33,71
32,58
26,32
27,29
26,71
28,32
0,473
0,217
0,788
0,361
33,32
30,77
34,11
34,30
Central ONL thickness, μm, mean 90,30 91,26 0,717
Superior
Temporal
Inferior
Nasal
Superior
Temporal
Inferior
Nasal
69,70
73,52
68,32
73,02
59,30
56,68
51,89
55,36
70,58
73,55
70,06
74,87
60,74
56,68
54,19
56,77
0,730
0,991
0,498
0,558
69,70
73,52
68,32
73,02
Central RPE, μm, mean 18,20 17,10 0,150
Superior
Temporal
Inferior
Nasal
Superior
Temporal
Inferior
Nasal
15,64
14,95
14,86
15,80
13,93
13,05
13,11
13,59
15,26
14,48
14,97
15,10
14,39
12,84
13,06
13,48
0,354
0,244
0,815
0,135
0,367
0,471
0,857
0,758
Central FR, μm, mean 90,75 89,87 0,483
Superior
Temporal
Inferior
Nasal
Superior
Temporal
Inferior
Nasal
81,39
81,77
80,57
83,14
79,23
77,98
76,80
78,82
80,81
81,23
80,29
82,19
78,48
77,55
76,52
78,26
0,434
0,456
0,690
0,264
0,176
0,439
0,597
0,337
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for the central one in MS ON- compared to the control 
group. IPL was significantly reduced in MS ON+ in con-
trast with MS ON- in all sectors except for the nasal outer 
ring. IPL was significantly thinner in CIS ON+ eyes compa-
red to the control group only in the superior outer ring. CIS 
ON- did not appear to have a significant reduction. 
Inner nuclear layer, outer Plexiform layer, ou-
ter nuclear layer, Retinal Pigment epithelium and 
Photoreceptor layer
Both MS ON+ and MS ON- patients did not demons-
trate statistically significant differences when compared to 
the Control Group. A trend was observed with an increase 
in thickness in some sectors of the INL-OPL and ONL-
-RPE layer although this was not statistically significant. 
CIS ON+ and ON- eyes exhibited the same trend.
Clinically isolated syndrome
Eyes with CIS ON+ and CIS ON- did not show statis-
tically significant differences between them in any retinal 
layer except for a reduction in the RPE central layer in CIS 
ON- (P<0.02).
dIsCussIon
Multiple sclerosis is a central nervous system disease 
characterized by inflammation and neuro-axonal degene-
ration. The eye itself is commonly affected by MS. Optic 
neuritis is a frequent inaugural sign of MS ant it can also 
develop during the course of this disease. During acute ON, 
fluorescein leakage has proved a disruption of the blood-
-retina barrier as well as showed retinal perivascular inflam-
mation (periphlebitis). Studies demonstrated that active 
periphlebitis could be a risk factor for relapses and brain 
lesions. Intermediate uveitis (pars planitis) can also occur 
in up to 15-25% of patients. 
Neuro-axonal degeneration affecting the retina can be 
structurally and functionally related to pathology of the 
visual pathways. Inflammation and activation of the micro-
glia have also been demonstrated in the inner retina of MS 
patients but the relationship between inflammation and neu-
rodegeneration needs more studies. 
Optical Coherence Tomography (OCT) has become one 
of the most important tools in ophthalmology practice and 
especially in neuro-ophthalmology practice. It is a fast, relia-
ble and non-invasive method that can provide high quality 
images of the optic nerve, retinal nerve fiber layer, macular 
volume and ganglion cell layer which can be relevant for 
diagnosis, prognosis and follow-up of different diseases.
In MS, OCT can have a potential role in quantifying 
axonal loss and assessing longitudinal alterations6. The 
first studies with time-domain OCT showed that peripapi-
llary RNFL thinning was associated with macular volume 
reduction in eyes with previous MS ON+.1 More recently 
spectral-domain OCT studies confirm that eyes with thinner 
macula are associated with reduced thickness of the macu-
lar RNFL, ganglion cell layer (GCL), and inner plexiform 
layer (IPL) thinning3,14.
The temporal and spatial associations between axonal 
injury and ganglion cell loss have yet to be determined, 
although retrograde degeneration of the RNFL has been 
implicated as an important mechanism leading to macular 
damage. It seems that in a subset of patients with MS, a 
disproportionate thinning of the macular inner and outer 
nuclear layers has been reported in the presence of normal 
peripapillary RNFL thickness and these patients may pre-
sent a MS-related macular pathology as a primary process 
independent of optic nerve pathology4.
Recently various protocols of segmentation of OCT 
images, both manual and automated11,14,15, have been used 
to quantify changes in different retinal layers in patients 
with MS, with variable levels of success10. These segmen-
tation algorithms rely on techniques such as edge detection, 
intensity variations, active contours, multiresolution hie-
rarchical support vector machines and graph-cut segmen-
tation. Most of these approaches introduce complex models 
or methodologies to obtain reliable results and are therefore 
very computationally intensive. Previous results of manual 
and automatic segmentation have yielded similar results 
insofar, except for the RNFL and INL layers. These layers 
are thinner than others making it difficult to determine their 
limits correctly. One study suggests that segmentation of 
both layers together with their neighboring layers, namely 
RNFL-GCL-IPL together, and similarly the INL-OPL, 
can be a method to overcome this issue. This approach is 
also applied by other widely used automatic segmentation 
methods. However, Spectralis OCT is effective in distin-
guishing and measuring these layers when compared to the 
Cirrus OCT used in the first studies.
In our study, we use a fast approach for automatic seg-
mentation of the 8 retinal layers: 1- retinal nerve fiber layer 
(RNFL); 2- ganglion cell layer (GCL); 3- inner plexiform 
layer (IPL); 4- inner nuclear layer (INL); 5- outer plexiform 
layer (OPL); 6- outer nuclear layer (ONL); 7- photorecep-
tor layer (FR); 8- retinal pigment epithelium (RPE). To 
validate our method in a real-world setting, we quantified 
retinal changes caused by ON in two separate cohorts of 
patients with MS and CIS, comparing them with a control 
group of healthy aged-matched individuals.
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Our results revealed a significant reduction in average 
macular layer and retinal nerve fiber layer in MS patients 
with previous episodes of optic neuritis and even in the 
absence of optic neuritis, when compared to the control 
group. However, there was no statistical significance in 
this reduction between MS ON+ and MS ON- except for 
a greater reduction in the superior sector in MS ON+ eyes. 
This finding is in line with previous studies that show 
a reduce thickness of both the macula and RNFL in MS 
patients10,11,12,14,15.
In our study, GCL and IPL layers were also thinned in 
both MS ON+ and MS ON- with this thickness being more 
pronounced in eyes with previous optic neuritis. Thinning 
in ON- eyes can perhaps be explained by subclinical epi-
sodes of optic neuritis, degeneration of the ganglion cells 
and their axons without inflammation or retrograde dege-
neration of MS lesions. This type of trans-synaptic dege-
neration has been reported in patients with homonymous 
hemianopia due to retrogeniculate lesions. Albrecht et al16 
applied manual segmentation to a similar cohort of patients 
obtaining the same results.
We did not detect alterations in other layers except for 
a trend in the increase in thickness in some sectors of the 
INL-OPL and ONL-RPE layer although this was not sta-
tistically significant. This can be because the ON episodes 
did not affect outer retinal layers or retrograde degenera-
tion does not have a part in altering outer retinal layer’s 
thickness. Some studies, however, show a thickening of the 
ONL + FR layer (and less pronounced of the INL+OPL) 
that may be mediated be the same retrograde degenera-
tion mechanism. Vitreous traction has also been implica-
ted but recently deemed unrelated7,8,9,13. Another plausible 
explanation can be the presence of the earlier mentioned 
retinal inflammation, with perivenous sheating and peri-
venous leakage, which occurs in eyes with AON within 
eight weeks of symptom onset5. This corroborates studies 
that refer to the dynamic changes occurring in deep retinal 
layers following AON, with a mean increased in ONL+FR 
layer at four months followed by a decreased in retinal thi-
ckness at about 4-12 months and similar thickness compa-
ring to baseline after four months13. Our results may be at 
this stage since none of the patients had had an episode of 
AON in the last year before OCT5,11.
Our study has some limitations. Firstly we did not sepa-
rate different MS types, which, in more aggressive types, 
can possibly have a more evident pathway of neuronal 
degeneration. Different follow-up times can also inter-
fere with the results. Standard OCT techniques, although 
offering high resolution imaging, still cannot achieve 
cellular-resolution imaging. Therefore it is not possible to 
determine if the alterations detected in our study are due to 
activation of microglia cells (Müller cells in the retina) in 
response to ganglion cell death, hypertrophic neuronal cell 
bodies, alterations in subretinal fluids or a combination of 
these factors. Future studies, perhaps with adaptive optics 
technology, can possibly shed a light in this phenomenon.
OCT can currently be considered an imaging biomarker 
of global CNS atrophy for both monitoring neuronal dege-
neration and assessing non-invasively effectiveness of the-
rapies that reduce neuroaxonal loss. We believe that gan-
glion cell atrophy that occurs so early in the course of MS 
is still undermined and could be reduced with valid neuro-
protective therapies during therapeutic window using OCT 
technology has a primary or secondary outcome metric for 
MS patients.
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